NEWS COMMENTARY

ADM Ventures invests in Seventure Partners' fund for the microbiome

Published:
November 09, 2020
Services:
Consumer
Activities:
Investment
by Thomas Hayes
Average importance

The size of investment was not disclosed. ADM has been aggressive in recent years in expanding its prebiotic and probiotic offerings, including a $244 million acquisition of Probiotics International in June 2018. By partnering with Seventure Partners, ADM is extending its reach in the ecosystem with a reputable partner. The venture firm has invested in microbiome companies since 2008, with notable investments including DayTwo and TargEDys. With food companies needing to master the role of the microbiome, finding ways to engage at an arm's length as ADM is doing will help your organization understand the future of this space, which still has a plethora of possibilities for exploration.

For the original news article, click here .


Further Reading

Ginkgo Bioworks to go public via $17.5 billion SPAC deal

News Commentary | May 13, 2021

Backed by Harry Sloan and Jeff Sagansky, this merger with Soaring Eagle Acquisition will give Ginkgo a pre‑money equity valuation of $15 billion, with an additional $2.5 billion for the combined entity – one of the biggest SPAC deals in recent times. This news comes on the heels of Zymergen's IPO ... To read more, click here.

Motif FoodWorks raises whopping $226 million Series B to commercialize ingredients for plant-based market

News Commentary | June 17, 2021

This funding is the biggest‑ever Series B round in food tech and brings Motif's total funding raised to date to $345 million. Motif will use this funding to focus more on its R&D and scale up its fermentation‑derived ingredient, a muscle protein, aimed to improve the flavor of plant‑based ... Not part of subscription

Bota Bio raises $100 million Series B for sustainable biomanufacturing

News Commentary | August 06, 2021

Led by Sequoia Capital China, this funding will help Bota Bio expand its integrated technology platform Bota Freeway from lab to pilot scale. This Series B round closely follows BASF's recent investment in the company, bringing Bota Bio's total funding to $145 million to date. The startup focuses on... Not part of subscription